These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20353624)

  • 1. Rivastigmine in the treatment of delirium in older people: a pilot study.
    Overshott R; Vernon M; Morris J; Burns A
    Int Psychogeriatr; 2010 Aug; 22(5):812-8. PubMed ID: 20353624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
    van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
    Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial.
    Gamberini M; Bolliger D; Lurati Buse GA; Burkhart CS; Grapow M; Gagneux A; Filipovic M; Seeberger MD; Pargger H; Siegemund M; Carrel T; Seiler WO; Berres M; Strebel SP; Monsch AU; Steiner LA
    Crit Care Med; 2009 May; 37(5):1762-8. PubMed ID: 19325490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
    Oldenbeuving AW; de Kort PL; Jansen BP; Kappelle LJ; Roks G
    BMC Neurol; 2008 Sep; 8():34. PubMed ID: 18803862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine in the treatment of postoperative delirium: a pilot clinical trial.
    Zaslavsky A; Haile M; Kline R; Iospa A; Frempong-Boadu A; Bekker A
    Int J Geriatr Psychiatry; 2012 Sep; 27(9):986-8. PubMed ID: 22886871
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
    Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
    Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study.
    Kumari V; Aasen I; ffytche D; Williams SC; Sharma T
    Neuroimage; 2006 Jan; 29(2):545-56. PubMed ID: 16181792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study.
    Simioni S; Cavassini M; Annoni JM; Métral M; Iglesias K; Rimbault Abraham A; Jilek S; Calmy A; Müller H; Fayet-Mello A; Giacobini E; Hirschel B; Du Pasquier RA
    Neurology; 2013 Feb; 80(6):553-60. PubMed ID: 23345635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke].
    Litvineneko IV; Odinak MM; Khlystov IuV; Perstnev SV; Fedorov BB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):36-41. PubMed ID: 21389938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.
    Massoudi N; Mohit B; Fathi M; Nooraei N; Hannani KK; ArianNik M
    Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5970. PubMed ID: 37485727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine in vascular dementia.
    Vincent S; Lane R
    Int Psychogeriatr; 2003; 15 Suppl 1():201-5. PubMed ID: 16191241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rivastigmine on mobility of patients with higher-level gait disorder: a pilot exploratory study.
    Gurevich T; Balash Y; Merims D; Peretz C; Herman T; Hausdorff JM; Giladi N
    Drugs R D; 2014 Jun; 14(2):57-62. PubMed ID: 24723147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
    Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G
    Am J Alzheimers Dis Other Demen; 2004; 19(6):333-9. PubMed ID: 15633941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive function in early clinical phase huntington disease after rivastigmine treatment.
    Sešok S; Bolle N; Kobal J; Bucik V; Vodušek DB
    Psychiatr Danub; 2014 Sep; 26(3):239-48. PubMed ID: 25191771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-month study of the efficacy of rivastigmine in patients with advanced moderate Alzheimer's disease.
    Karaman Y; Erdoğan F; Köseoğlu E; Turan T; Ersoy AO
    Dement Geriatr Cogn Disord; 2005; 19(1):51-6. PubMed ID: 15383747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of rivastigmine capsules in patients with traumatic brain injury.
    Silver JM; Koumaras B; Meng X; Potkin SG; Reyes PF; Harvey PD; Katz DI; Gunay I; Arciniegas DB
    Brain Inj; 2009 Feb; 23(2):123-32. PubMed ID: 19191091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rivastigmine on memory and cognition in multiple sclerosis.
    Shaygannejad V; Janghorbani M; Ashtari F; Zanjani HA; Zakizade N
    Can J Neurol Sci; 2008 Sep; 35(4):476-81. PubMed ID: 18973065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    Kalisvaart CJ; Boelaarts L; de Jonghe JF; Hovinga IM; Kat MG
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1501-4. PubMed ID: 15481575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
    Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M
    Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
    Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
    Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.